Prescriptions via telehealth are significantly more common for patients taking obesity medicines (Zepbound, Saxenda, Wegovy)
Ann Intern Med 2022;175:74-83.ArticlePubMed 876
The following sections review the pharmacology and clinical characteristics of currently available GLP-1 RAs that should be considered when applying the clinical recommendations discussed above to individual patients with T2D
Summary: Hair loss from GLP-1 medications is typically temporary telogen effluvium caused by rapid weight loss and nutritional changes, manageable through adequate protein intake, micronutrient optimisation, and moderating weight reduction rate
It might hurt more or not work as well
Why Pregnant Women Should Avoid Tirzepatide Given the information available, it is generally advised that pregnant women should avoid taking tirzepatide unless it is absolutely necessary for their health